Impact of propensity to COVID-19 vaccination/vaccine on influenza vaccination from willingness to behavior among older adults in rural China
To explore impact of the propensity to coronavirus disease 2019 (COVID-19) vaccine/vaccination on influenza vaccination from willingness to behavior after COVID-19 pandemic among older adults in rural China. A combined study involving a cross-sectional survey for the willingness of influenza vaccination, a health education momentary intervention and a community intervention program were conducted from September 11<sup>th</sup> to 16<sup>th</sup>, 2023 among rural older adults in China. Totally 3138 individuals were investigated in this study with 1923 (61.3%) willing to receive influenza vaccination. After the momentary intervention, 47.8% (582/1215) individuals changed to be willing to receive influenza vaccination. There were 1440 (78.8%) vaccinated. The influenza vaccination willingness rate was significantly higher in the participants willing to receive COVID-19 vaccine booster dose vaccination than the participants unwilling to (69.4% <i>vs</i>. 37.7%, adjusted OR [aOR] = 2.671, 95% CI 2.211-3.227, <i>p</i> < .001), as well as for the influenza vaccination willingness change rate (52.2% <i>vs</i>. 41.7%, aOR = 1.303, 95% CI 1.022-1.662, <i>p</i> < .05) and the influenza vaccination behavior rate (79.7% <i>vs</i>. 74.9%, aOR = 1.337, 95% CI 1.002-1.784, <i>p</i> < .05). The influenza vaccination behavior rate was significantly higher in those positive toward COVID-19 vaccine effectiveness or safety overall (80.0% <i>vs</i>. 74.9%, aOR = 1.394, 95% CI 1.065-1.823; 80.6% <i>vs</i>. 70.9%, aOR = 1.850, 95% CI 1.395-2.454; both <i>p</i> < .05). There was a positive impact of COVID-19 vaccine/vaccination on influenza vaccination from willingness to behavior among the older adults in rural China after COVID-19 pandemic, suggesting that integrating health education of related pathogens and vaccines might promote influenza vaccination.
Authors
- Ninghua Huang (ORCID: https://orcid.org/0009-0002-5072-2645)
- Qing‐Bin Lu (ORCID: https://orcid.org/0000-0002-2877-5815)
- Jing Zeng (ORCID: https://orcid.org/0000-0002-4736-4210)
- Wan−Xue Zhang (ORCID: https://orcid.org/0000-0002-3154-9309)
- Yiguo Zhou (ORCID: https://orcid.org/0000-0002-2172-4396)
- Mingting Wang
- Fuqiang Cui (ORCID: https://orcid.org/0000-0002-9592-4286)
- Yuanshan Zhang
- Lili Wang (ORCID: https://orcid.org/0000-0002-6559-9910)
- Shanshan Zhang (ORCID: https://orcid.org/0000-0002-2104-9909)
- Qin‐Yi Ma
- Xiyu Zhang (ORCID: https://orcid.org/0000-0003-3244-3554)
- Wanna Shi
- Mingjun Yuan
- Sihui Zhang (ORCID: https://orcid.org/0009-0004-4780-8362)
- Yang Han (ORCID: https://orcid.org/0000-0003-0529-6085)
- Tianshuo Zhao (ORCID: https://orcid.org/0000-0001-5279-3215)
- Yaqiong Liu (ORCID: https://orcid.org/0000-0001-5472-1290)
- Juan Du
Institutions
- Chinese Center For Disease Control and Prevention (CN)
- Peking University (CN)
- Southerners on New Ground (US)
- Taiwan Centers for Disease Control (TW)
Publication Details
- Journal
- Human Vaccines & Immunotherapeutics
- Published
- 2024-11-13
- DOI
- https://doi.org/10.1080/21645515.2024.2428017
- Citations
- 3
- Primary Topic
- Vaccine Coverage and Hesitancy
- Type
- article
- Field-Weighted Citation Impact
- 1.58
Funders
- Bill and Melinda Gates Foundation
- National Natural Science Foundation of China
- Peking University
- National Key Research and Development Program of China
- Fundamental Research Funds for the Central Universities
- Peking University Health Science Center